See feature articles below:

 

About Broad Street Alerts:

Big opportunities in Small Cap’s

 

Broad Street Alerts recent profiles and track record, 217% in verifiable potential gains for our members on the last 4 small cap alerts alone!

February 10th, 2016- (NASDAQ: BONT) opened $1.65/share hit a high of $3.00/share within 30 days our member potential gains- 83%

March 7th, 2016-(NYSE-MKT: FSI) opened at .91/share and hit 1.10/share within 5 days for gains of 21% for our members.

March 24th, 2016- (NASDAQ: ICLD) opened at $.77/share it a high of $1.15/share within 2 days for gains of 49% for our members.

April 11th, 2016 – (NASDAQ: FNJN) called at $1.07/share hit $1.76/share in 3 days for 64% gains for our members.

 

These are numbers that make traders drool. Any trader in any market would fall all over themselves to see numbers like this. So if you’ve been on the fence, perhaps it’s time to start doing some research and verify our numbers for yourself. We are constantly raising the bar and separate ourselves from the rest of the small-cap newsletters as the best in business.

We know with a large following comes a large responsibility as we have everyone from institutional investors to the beginner following our profiled securities in our newsletters. This is something we take very seriously always seeking small cap growth companies that have both near and long-term potential for our members.

***Get our small cap profiles, special situation and watch alerts in real time. We are now offering our VIP SMS/text alert service for free, simply text the word “Alerts” to the phone number 25827 from your cell phone.

 

Report for: Arch Theraputics

Arch Therapeutics Receives Notice of Allowance for Patent Covering Systemic Applications for Self-Assembling Peptides

U.S. Patent Addresses Use of the Self-Assembling Peptide Barrier Technology to Treat Disorders Involving Leaky Tight Junctions and Extracellular Matrix

FRAMINGHAM, MA — (Marketwired) — 04/25/16 — Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), developer of the AC5 Surgical Hemostatic Device™ (AC5™) for use in controlling bleeding and fluid loss in order to provide faster and safer surgical and interventional care, received a notice of allowance from the U.S. Patent Office for a broad method-of-use patent that covers systemically administering the Company’s self-assembling technology for treating damaged extracellular matrix and leaky tight junctions.

Many disorders are associated with leakage around blood vessels and within the tight junctions between cells. Such leakage can lead to fluid invading the tissues, causing a loss in blood pressure, organ dysfunction or failure, and death. Some examples include inflammatory bowel disease, sepsis and ischemic stroke.

Dr. Terrence W. Norchi, President and CEO of Arch Therapeutics, said, “This important patent lends additional support to Arch’s planned products. It is another example of Arch’s inventiveness in exploring better ways to address a range of areas of unmet or poorly met medical needs with our self-assembling peptide technology.”

Arch has filed its own patent applications and, in addition, has licensed worldwide exclusive rights to certain patents and patent applications assigned jointly to MIT and Versitech Limited, the technology transfer company of the University of Hong Kong, and worldwide non-exclusive rights to another portfolio of patents assigned jointly to MIT and Versitech Limited. The applications and rights cover self-assembling compositions and methods of making and using such compositions for medical applications, including stopping bleeding; preventing the movement of bodily fluids, contaminants, etc., within or on the human body; preventing adhesions; treatment of leaky or damaged tight junctions; and reinforcement of weak or damaged vessels, such as aneurysms, with patents covering this technology in the United States, Europe, Japan, Canada, Israel, Australia, Hong Kong and China. Additional patent applications are pending in multiple jurisdictions.

About Arch Therapeutics, Inc.

Arch Therapeutics, Inc. is a medical device company developing a novel approach to stop bleeding (hemostasis) and control leaking (sealant) during surgery and trauma care. Arch is developing products based on an innovative self-assembling peptide technology platform to make surgery and interventional care faster and safer for patients. Arch’s flagship development stage product candidate, known as the AC5 Surgical Hemostatic Device™, is being designed to achieve hemostasis in surgical procedures.

 

 

Source – Company Press Release

See feature articles below:

About Broad Street Alerts:
Big opportunities in Small Cap’s

Broad Street Alerts recent profiles and track record, 153% in verifiable potential gains for our members on the last 3 small cap alerts alone!

February 10th, 2016- (NASDAQ: BONT) opened $1.65/share hit a high of $3.00/share within 30 days our member potential gains- 83%

March 7th, 2016-(NYSE-MKT: FSI) opened at .91/share and hit 1.10/share within 5 days for gains of 21% for our members.

March 24th, 2016- (NASDAQ: ICLD) opened at $.77/share it a high of $1.15/share within 2 days for gains of 49% for our members.

These are numbers that make traders drool. Any trader in any market would fall all over themselves to see numbers like this. So if you’ve been on the fence, perhaps it’s time to start doing some research and verify our numbers for yourself. We are constantly raising the bar and separate ourselves from the rest of the small-cap newsletters as the best in business.

We know with a large following comes a large responsibility as we have everyone from institutional investors to the beginner following our profiled securities in our newsletters. This is something we take very seriously always seeking small cap growth companies that have both near and long-term potential for our members.

***Get our small cap profiles, special situation and watch alerts in real time. We are now offering our VIP SMS/text alert service for free, simply text the word “Alerts” to the phone number 25827 from your cell phone.

The following PR and supporting news may give insight into possible upside to (Nasdaq: ULTR) recent onslaught of troubles. 

Latest PR-  (NASDAQ: ULTR)

NASSAU, Bahamas, May 02, 2016 (GLOBE NEWSWIRE) — Ultrapetrol (Bahamas) Limited (ULTR) (“Ultrapetrol” or the “Company”) today that it is in on-going negotiations with its secured lenders to extend its existing forbearance agreements, which expired April 30, 2016, through May 31, 2016.

The Company is in continuing discussions with all of its secured creditors and expressed its confidence that a consensual financial restructuring can be achieved in order to provide Ultrapetrol with a sustainable capital structure that supports the Company’s long-term business plan and results in long-term value generation for the benefit of all stakeholders. During this period, the Company believes that it has sufficient liquidity to fully fund all aspects of its operations and to conduct business as usual, including making full and timely payments to employees, vendors, suppliers, and trading counterparties.

About Ultrapetrol
Ultrapetrol is an industrial transportation company serving the marine transportation needs of its clients in the markets on which it focuses. It serves the shipping markets for containers, grain and soy bean products, forest products, minerals, crude oil, petroleum, and refined petroleum products, as well as the offshore oil platform supply market with its extensive and diverse fleet of vessels. These include river barges and pushboats, platform supply vessels, tankers and two container feeder vessels. More information on Ultrapetrol can be found at www.ultrapetrol.net.

Forward-Looking Language
The forward-looking statements in this press release are based upon various assumptions, many of which are based, in turn, upon further assumptions, including without limitation, our management’s examination of historical operating trends, data contained in our records and other data available from third parties. Although we believe that these assumptions were reasonable when made, because these assumptions are inherently subject to significant uncertainties and contingencies which are difficult or impossible to predict and are beyond our control, we cannot assure you that we will achieve or accomplish these expectations, beliefs or projections.

In addition to these important factors, other important factors that, in our view, could cause actual results to differ materially from those discussed in the forward-looking statements include future operating or financial results; pending or recent acquisitions, business strategy and expected capital spending or operating expenses, including dry docking and insurance costs; general market conditions and trends, including charter rates, vessel values, and factors affecting vessel supply and demand; our ability to obtain additional financing; our financial condition and liquidity, including our ability to obtain financing in the future to fund capital expenditures, acquisitions and other general corporate activities; our expectations about the availability of vessels to purchase, the time that it may take to construct new vessels, or vessels’ useful lives; our dependence upon the abilities and efforts of our management team; changes in governmental rules and regulations or actions taken by regulatory authorities; adverse weather conditions that can affect production of the goods we transport and navigability of the river system; the highly competitive nature of the oceangoing transportation industry; the loss of one or more key customers; fluctuations in foreign exchange rates and devaluations; potential liability from future litigation; and other factors. Please see our filings with the Securities and Exchange Commission for a more complete discussion of these and other risks and uncertainties.

 

Ultra Petroleum files for Chapter 11-

Houston, Texas-based independent producer Ultra Petroleum and seven subsidiaries on Friday filed for protection from creditors under Chapter 11 of the U.S. Bankruptcy Code, the latest oil and gas company to succumb to the prolonged slump in energy prices.

Ultra listed $1.28 billion in assets and $3.92 billion in debt in court papers filed in Houston and reviewed by Kallanish Energy.

The producer’s primary assets are gas-producing properties in Wyoming, as well as some assets in Pennsylvania and crude oil properties in Utah, according to Bankruptcy Court papers.

“The low commodity prices, and especially the low natural gas prices that prevailed in 2015 and have continued through the first four months of 2016, have had a devastating impact,” Ultra Chief Financial Officer Garland Shaw said in a filing explaining events that led to the bankruptcy.

Court documents show five firms hold at least 5.2% of Ultra’s equity, including Disciplined Growth Investors (9.1% of company equity), Invesco (7.9%), Vanguard (6.7%), Blackrock (5.7%), and State Street (5.2%).

The largest unsecured investor, owed a disputed $1.46 billion is in the form of private placement notes issued by Ultra Resources in care of Morgan, Lewis & Bockius.

Between March and early April, Ultra missed a series of principal and interest payments owed to lenders and bondholders. And on April 14, the company was sued by pipeline operator Sempra Rockies Marketing for failing to pay transport fees.

The oil market is suffering its worst slump in decades, brought on by a glut of production. Much of the problem can be traced to a record-breaking surge in U.S. oil production that wouldn’t have been possible without a tremendous amount of debt.

Many independent drillers outspent cash flow even when oil was $100 a barrel, and made up the difference with bank loans and high-yield bonds. In the meantime, crude is hugging the $40/Bbl range.
Source: Globe Newswire, Kallanish Energy News, & ACAD Sharp Charts

Broad street alerts has not been compensated for the mention of any publicly traded companies in this article nor do we own positions in any of the companies in this article.

 

 

Hot small cap stocks

small cap stock picks

Biotech stocks

FDA approval stocks

FDA calendar

Trade stocks

Become a day trader

Day trade stocks for a living

PDUFA date set

micro cap stocks

Best stocks 2016

Hottest small cap stocks

Best stock picks

Who to follow for stock picks

Apple news stock picks

Stock picks on apple news

See feature articles below:

 

About Broad Street Alerts:

Big opportunities in Small Cap’s

 

Broad Street Alerts recent profiles and track record, 217% in verifiable potential gains for our members on the last 4 small cap alerts alone!

February 10th, 2016- (NASDAQ: BONT) opened $1.65/share hit a high of $3.00/share within 30 days our member potential gains- 83%

March 7th, 2016-(NYSE-MKT: FSI) opened at .91/share and hit 1.10/share within 5 days for gains of 21% for our members.

March 24th, 2016- (NASDAQ: ICLD) opened at $.77/share it a high of $1.15/share within 2 days for gains of 49% for our members.

April 11th, 2016 – (NASDAQ: FNJN) called at $1.07/share hit $1.76/share in 3 days for 64% gains for our members.

These are numbers that make traders drool. Any trader in any market would fall all over themselves to see numbers like this. So if you’ve been on the fence, perhaps it’s time to start doing some research and verify our numbers for yourself. We are constantly raising the bar and separate ourselves from the rest of the small-cap newsletters as the best in business.

We know with a large following comes a large responsibility as we have everyone from institutional investors to the beginner following our profiled securities in our newsletters. This is something we take very seriously always seeking small cap growth companies that have both near and long-term potential for our members.

***Get our small cap profiles, special situation and watch alerts in real time. We are now offering our VIP SMS/text alert service for free, simply text the word “Alerts” to the phone number 25827 from your cell phone.

 

Report for: DSG Global

 

DSG Global New Tournament Solutions Reaches 125 New Courses On Board

SURREY, BC / ACCESSWIRE / May 2, 2016 / The new Tournament Solutions Division of golf technology company, DSG GLOBAL INC. (OTCQB: DSGT), is on a winning streak as it reaches its 125th course using its award-winning tournament management software.

Image: https://www.accesswire.com/uploads/TS%205-3%201.jpg

DSG recently acquired Impact Tournament Solutions, along with their team of experts, to run the Tournament Solutions Division of DSG. The tournament management software is widely considered the most user friendly tournament software in the business and its real-time scoring application is a popular upgrade.

In the last two weeks, 6 new courses, all properties of Golf B.C., have joined the winning team.

They are Gallagher’s Canyon Golf & Country Club, Arbutus Ridge Golf Club, Mayfair Lakes Golf Club, Nicklaus North Golf Course, Okanagan Golf Club, and Furry Creek Golf Course.

Image: https://www.accesswire.com/uploads/NN%2017%201a.jpg

Nicklaus North Golf Course 17th Hole

“This is a fantastic launch for the new division,” said Brian Haydamack, VP, Tournament Solutions. “It’s really quite incredible to sign all of these great courses to our growing list of customers in just a couple of weeks.”

“The ROI for courses using the software is incredible,” said Robert ‘Bob’ Silzer, Sr., CEO & President of DSG Global. “We’re talking minimum annual profits of $11,500 for the typical course running the average number of tournaments.”

As part of the launch of the new division, DSG has been offering a 30 day free “test drive” of the software for any course that wants to try it out as well as a new, aggressive pricing structure that makes the deal very attractive for courses.

“There’s really no reason for any course to pass on this opportunity,” continued Haydamack. “This is instant ROI and is so easy to use. The proof is in the sudden spike in sales and customer satisfaction.”

Book a 30 Day Free Test Drive: http://impactts.ca/download-a-demo/

Find out more about the Tournament Solution Division: http://www.dsgtag.com/tournamentsolutions/

Contact the Tournament Solutions Division directly:

Phone: 1-855-224-5600

Email: sales-ts@dsgtag.com

About DSG Global Inc.

DSG Global, Inc. is a technology company that offers a variety of products for fleet management in several industries. Its clients are using DSG’s patented technology to significantly reduce costs, increase safety and enhance customer satisfaction. DSG has historically focused on the golf industry where golf course operators manage their fleet of golf carts, turf equipment, and utility vehicles remotely using DSG’s SaaS technology and advanced GPS hardware. Their technology is deployed in over 15,000 vehicles on 300 courses worldwide. DSG is aggressively expanding into new revenue streams through its R3 advertising program, golf tournament software, licensing and distribution of new technology like the all-electric, low speed vehicle, the 100e. You can learn more and visit DSG at dsgtag.com or FACEBOOK or TWITTER.

 

Source – Company Press Release

 

 

Broad street alerts has not been compensated for the mention of any publicly traded companies in this article nor do we own positions in any of the companies in this article.

 

Broad Street Alerts was previously compensated eighteen thousand five hundred dollars by star media llc for the mention of FNJN however, that contract has expired.

 

 

Stock market

 

Hot small cap stocks

 

small cap stock picks

 

Biotech stocks

 

FDA approval stocks

 

FDA calendar

 

See feature articles below:

 

About Broad Street Alerts:

Big opportunities in Small Cap’s

 

Broad Street Alerts recent profiles and track record, 217% in verifiable potential gains for our members on the last 4 small cap alerts alone!

February 10th, 2016- (NASDAQ: BONT) opened $1.65/share hit a high of $3.00/share within 30 days our member potential gains- 83%

March 7th, 2016-(NYSE-MKT: FSI) opened at .91/share and hit 1.10/share within 5 days for gains of 21% for our members.

March 24th, 2016- (NASDAQ: ICLD) opened at $.77/share it a high of $1.15/share within 2 days for gains of 49% for our members.

April 11th, 2016 – (NASDAQ: FNJN) called at $1.07/share hit $1.76/share in 3 days for 64% gains for our members.

 

These are numbers that make traders drool. Any trader in any market would fall all over themselves to see numbers like this. So if you’ve been on the fence, perhaps it’s time to start doing some research and verify our numbers for yourself. We are constantly raising the bar and separate ourselves from the rest of the small-cap newsletters as the best in business.

We know with a large following comes a large responsibility as we have everyone from institutional investors to the beginner following our profiled securities in our newsletters. This is something we take very seriously always seeking small cap growth companies that have both near and long-term potential for our members.

***Get our small cap profiles, special situation and watch alerts in real time. We are now offering our VIP SMS/text alert service for free, simply text the word “Alerts” to the phone number 25827 from your cell phone.

 

Report for: FLASR, Inc.

FLASR, Inc. Nears Completion of Restructuring and Securing of a $3,000,000 Equity Credit Line!

ATLANTA–(BUSINESS WIRE)– FLASR, Inc. (OTCPink: FLSR) is almost complete with the restructuring of the Company’s stock. A reverse split has been completed and in effect since February 2016 and the share structure is much more attractive to investors and shareholders alike. CEO of FLASR, Inc. founding visionary Everett Dickson is quoted as saying, “We could not be happier with the new reduced debt structure and credit facility. I personally feel it is much more conducive to attracting new long term investors. Furthermore, with the funding we have in place, the Company will be able to fill several large orders and substantially boost revenues!”

ABOUT FLASR:

Atlanta-based, FLASR (OTCPink: FLSR), is a publicly traded company, and a first-of-its-kind tobacco accessory producer, targeting moist snuff users in the U.S. Founded in 2012, the company thoroughly researched this growing industry and recognized the need for more discreet and convenient disposal of moist tobacco by-product. The result is FLASR’s 4-oz. pocket-size, portable tobacco flask, with unique bottle designs and revolutionary Thumb-Lock Twist Cap. Visit FLASR.com or view OTC market listing; and follow them on Facebook, Twitter or Instagram.

For more information or to purchase a FLASR, visit FLASR.com.

The Company sells through wholesale distribution to convenience stores and direct sales online through its website, www.FLASR.com, and amazon.com, pocket-sized, portable spittoons, or FLASR, which allow moist snuff users to contain tobacco byproducts. A FLASR is a broad flattened necked vessel used especially to contain moist tobacco by product. Our FLASR are 3.25 ounces, made of durable polypropylene and have a thumb lock twist for one-handed operation. Polyethelene is known for its outstanding toughness (impact strength), has moderate stiffness (tensile strength) and is used in many products including stadium drink cups, reusable food containers (Tupperware), automotive interiors parts, and products with a living hinge design. The unit and its materials are also highly recyclable. FLASR is reusable, but it has a limited life span. FLASR’s size and shape make it unobtrusive so individuals can easily conceal it on their person and use it openly in public environments without drawing unwanted attention.

 

 

Source –

 

 

Broad street alerts has not been compensated for the mention of any publicly traded companies in this article nor do we own positions in any of the companies in this article.

Broad Street Alerts was previously compensated eighteen thousand five hundred dollars by star media llc for the mention of FNJN however, that contract has expired.

 

Stock market

 

Hot small cap stocks

 

small cap stock picks

 

Biotech stocks

 

FDA approval stocks

 

FDA calendar

 

 

See feature articles below:

About Broad Street Alerts:
Big opportunities in Small Cap’s

Broad Street Alerts recent profiles and track record, 217% in verifiable potential gains for our members on the last 4 small cap alerts alone!

February 10th, 2016- (NASDAQ: BONT) opened $1.65/share hit a high of $3.00/share within 30 days our member potential gains- 83%

March 7th, 2016-(NYSE-MKT: FSI) opened at .91/share and hit 1.10/share within 5 days for gains of 21% for our members.

March 24th, 2016- (NASDAQ: ICLD) opened at $.77/share it a high of $1.15/share within 2 days for gains of 49% for our members.

April 11th, 2016 – (NASDAQ: FNJN) called at $1.07/share hit $1.76/share in 3 days for 64% gains for our members.
These are numbers that make traders drool. Any trader in any market would fall all over themselves to see numbers like this. So if you’ve been on the fence, perhaps it’s time to start doing some research and verify our numbers for yourself. We are constantly raising the bar and separate ourselves from the rest of the small-cap newsletters as the best in business.

We know with a large following comes a large responsibility as we have everyone from institutional investors to the beginner following our profiled securities in our newsletters. This is something we take very seriously always seeking small cap growth companies that have both near and long-term potential for our members.

***Get our small cap profiles, special situation and watch alerts in real time. We are now offering our VIP SMS/text alert service for free, simply text the word “Alerts” to the phone number 25827 from your cell phone.

Report for: QKL Stores

QKL Stores Inc. Announces Fourth Quarter and Full Year 2015 Financial Results

Source – Company Press Release
Broad street alerts has not been compensated for the mention of any publicly traded companies in this article nor do we own positions in any of the companies in this article.

Broad Street Alerts was previously compensated eighteen thousand five hundred dollars by star media llc for the mention of FNJN however, that contract has expired.
Stock market

Hot small cap stocks

small cap stock picks

Biotech stocks

FDA approval stocks

FDA calendar